University of Texas Health Science Center at Houston: New antibody shows therapeutic effects in mice with Alzheimer's disease
September 08, 2022
September 08, 2022
HOUSTON, Texas, Sept. 8 (TNSjou) -- The University of Texas Health Science Center at Houston issued the following news on Sept. 7, 2022:
A newly developed agonistic antibody reduced the amyloid pathology in mice with Alzheimer's disease, signaling its promise as a potential treatment for the disease, according to a team of researchers at UTHealth Houston.
Research led by senior author Zhiqiang An, PhD, professor and Robert A. Welch Distinguished University Chair in . . .
A newly developed agonistic antibody reduced the amyloid pathology in mice with Alzheimer's disease, signaling its promise as a potential treatment for the disease, according to a team of researchers at UTHealth Houston.
Research led by senior author Zhiqiang An, PhD, professor and Robert A. Welch Distinguished University Chair in . . .